Sinofn Health
The United Kingdom represents one of the most sophisticated nutraceutical markets globally. With consumers increasingly prioritizing preventive healthcare, clean-label transparency, and bio-available formulations, UK brands are looking for manufacturing partners that offer more than just production capacity—they require R&D intelligence and regulatory assurance.
Post-Brexit regulatory alignment with the Food Standards Agency (FSA) and Medicines and Healthcare products Regulatory Agency (MHRA) requires a specialized approach to formulation compliance. SINOFN provides a bridge for UK companies, ensuring that every product—from GABA sleep aids to PKU dietary foods—meets strict EU/UK safety standards while benefiting from the manufacturing efficiency of China’s top-tier facilities.
Our methodology focuses on the "Information Gain" model. We don't just supply products; we supply market-ready solutions. Our R&D team, led by experts from the Chinese Academy of Sciences and international specialists, works to customize textures, bioavailability, and packaging to match the preferences of British consumers who demand sustainability and efficacy.
Founded in 2012, SINOFN has evolved from a clinical research entity into a global OEM/ODM powerhouse. We integrate high-tech manufacturing with a deep understanding of nutritional metabolism, specifically supporting specialized dietary needs for Phenylketonuria (PKU).
Our facilities are FSSC 22000, HACCP, and ISO certified, utilizing state-of-the-art HPLC/GC-MS testing to ensure purity. Whether for a startup or a retail giant, we scale production seamlessly.
Yes. Our formulation team understands the specific requirements of the UK Food Standards Agency. We provide support for ingredient validation to ensure your product is shelf-ready for the British market.
Absolutely. We specialize in custom OEM development. From stabilizing sensitive probiotic strains to formulating innovative energy gels, our lab provides pilot runs to perfect the formula before mass production.